News Shire launches potential blockbuster dry eye drug in US Xiidra could be ophthalmology blockbuster.
News Genzyme and AZ fall foul of UK pharma code Companies named in adverts after breaching code of practice.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
